Drug Development

Felicity Thomas is the former Associate Editorial Director of Pharmaceutical Technology, Pharmaceutical Technology Europe, BioPharm International.

Articles

Patient-centric drug development is becoming more important in the bio/pharma industry.

Designed with the Patient in Mind

Catalent invests $5 million in hot melt extrusion capabilities at Somerset, NJ facility. 

Catalent Expands HME Capabilities

3M Drug Delivery Systems UK organization has revealed that it is relocating its R&D team to the Charnwood Campus, which is an officially designated Life Sciences Opportunity Zone in Loughborough, United Kingdom

3M Relocates R&D to Life Sciences Opportunity Zone in Loughborough, UK

Novartis’ Sandoz resubmitted its biologics license application (BLA) for a proposed biosimilar pegfilgrastim to FDA in response to a 2016 complete response letter from the agency.

Sandoz Resubmits BLA for Biosimilar to Amgen’s Neulasta

Pharmaceutical Technology and BioPharm International will present a Keynote Session on Meeting Bioprocessing Manufacturing Capacity Demands on Wednesday, April 3, 2019, during INTERPHEX 2019 at the Javits Center in New York City.

Biologic Drug Manufacturing Capacity on the Agenda for INTERPHEX 2019 Keynote Series

The acquisition is expected to expand CURE Pharmaceutical’s technology platform in oral drug delivery.

CURE Pharmaceutical to Acquire Chemistry Holdings

Characterizing particles and understanding bulk powder behavior is critical to get the best pharma product.


Particles on Best Behavior

Lyndsey Johnson, PhD, is a project scientist and program manager for IntraStem at Locate Bio Limited

James E. Dixon, PhD, is an assistant professor at the University of Nottingham

Kevin M. Shakesheff,* PhD, is a professor at the University of Nottingham and also chief scientific officer at Locate Bio

Intracellular strategies offer an effective alternative approach to deliver a range of therapeutic proteins. 


Advanced Cell Penetrating Peptide Systems for Gene Therapy

Gayatri C.Patel, M.Pharm, PhD, is associate professor in the Department of Pharmaceutics & Pharmaceutical Technology, Ramanbhai Patel College of Pharmacy at the Charotar University of Science and Technology, Changa Campus, Changa- 388 421, Anand, Gujarat, India, gayatripatel.ph@charusat.ac.in, +91 2697 265162.

Chintan Patel is a researcher in the Department of Biotechnology, Zydus Research Centre, Cadila Healthcare Ltd., Ahmedabad, Gujarat, India. 

Sanjay Bandyopadhyay, PhD, is vice-president in the Department of Biotechnology, Zydus Research Centre, Cadila Healthcare Ltd., Ahmedabad, Gujarat, India

It is important to address manufacturing problems associated with the shorter shelf-life of pegylated L-asparaginase (pegaspargase) upon long-term storage in the form of a solution. 

Degradation Pathways: A Case Study with Pegylated L-Asparaginase

Cynthia A. Challener is a contributing editor to Pharmaceutical Technology.

Confidence in the quality systems and scientific competence of the API manufacturing team is essential.

Formulation and Drug Delivery